vs
ARDELYX, INC.（ARDX）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是ARDELYX, INC.的2.2倍（$212.2M vs $94.5M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -39.8%，领先58.6%），ARDELYX, INC.同比增速更快（27.5% vs 8.6%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs 11.1%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
ARDX vs RAMP — 直观对比
营收规模更大
RAMP
是对方的2.2倍
$94.5M
营收增速更快
ARDX
高出18.9%
8.6%
净利率更高
RAMP
高出58.6%
-39.8%
两年增速更快
ARDX
近两年复合增速
11.1%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $212.2M |
| 净利润 | $-37.6M | $39.9M |
| 毛利率 | — | 71.9% |
| 营业利润率 | — | 18.6% |
| 净利率 | -39.8% | 18.8% |
| 营收同比 | 27.5% | 8.6% |
| 净利润同比 | — | 255.7% |
| 每股收益（稀释后） | $-0.15 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXRAMP
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $212.2M | ||
| Q3 25 | $110.3M | $199.8M | ||
| Q2 25 | $97.7M | $194.8M | ||
| Q1 25 | $74.1M | $188.7M | ||
| Q4 24 | $116.1M | $195.4M | ||
| Q3 24 | $98.2M | $185.5M | ||
| Q2 24 | $73.2M | $176.0M |
净利润ARDXRAMP
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $39.9M | ||
| Q3 25 | $-969.0K | $27.4M | ||
| Q2 25 | $-19.1M | $7.7M | ||
| Q1 25 | $-41.1M | $-6.3M | ||
| Q4 24 | $4.6M | $11.2M | ||
| Q3 24 | $-809.0K | $1.7M | ||
| Q2 24 | $-16.5M | $-7.5M |
毛利率ARDXRAMP
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 71.9% | ||
| Q3 25 | 96.4% | 70.2% | ||
| Q2 25 | 87.3% | 70.1% | ||
| Q1 25 | 83.4% | 69.3% | ||
| Q4 24 | 84.3% | 71.9% | ||
| Q3 24 | 84.0% | 72.4% | ||
| Q2 24 | 87.1% | 70.6% |
营业利润率ARDXRAMP
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 18.6% | ||
| Q3 25 | 4.2% | 10.7% | ||
| Q2 25 | -14.7% | 3.7% | ||
| Q1 25 | -49.0% | -6.1% | ||
| Q4 24 | 7.0% | 7.5% | ||
| Q3 24 | 2.3% | 4.0% | ||
| Q2 24 | -18.6% | -3.0% |
净利率ARDXRAMP
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | 18.8% | ||
| Q3 25 | -0.9% | 13.7% | ||
| Q2 25 | -19.5% | 4.0% | ||
| Q1 25 | -55.5% | -3.3% | ||
| Q4 24 | 4.0% | 5.7% | ||
| Q3 24 | -0.8% | 0.9% | ||
| Q2 24 | -22.5% | -4.3% |
每股收益（稀释后）ARDXRAMP
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $0.62 | ||
| Q3 25 | $0.00 | $0.42 | ||
| Q2 25 | $-0.08 | $0.12 | ||
| Q1 25 | $-0.17 | $-0.10 | ||
| Q4 24 | $0.01 | $0.17 | ||
| Q3 24 | $0.00 | $0.03 | ||
| Q2 24 | $-0.07 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $403.4M |
| 总债务越低越好 | $203.5M | — |
| 股东权益账面价值 | $148.6M | $962.3M |
| 总资产 | $504.5M | $1.3B |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势，按日历期对齐
现金及短期投资ARDXRAMP
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $403.4M | ||
| Q3 25 | $42.7M | $376.9M | ||
| Q2 25 | $90.0M | $371.1M | ||
| Q1 25 | $30.8M | $420.8M | ||
| Q4 24 | $64.9M | $384.3M | ||
| Q3 24 | $47.4M | $348.4M | ||
| Q2 24 | $41.9M | $342.7M |
总债务ARDXRAMP
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | — | ||
| Q3 25 | $202.1M | — | ||
| Q2 25 | $201.4M | — | ||
| Q1 25 | $151.3M | — | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
股东权益ARDXRAMP
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $962.3M | ||
| Q3 25 | $154.3M | $943.8M | ||
| Q2 25 | $139.5M | $947.8M | ||
| Q1 25 | $145.7M | $948.9M | ||
| Q4 24 | $173.3M | $957.7M | ||
| Q3 24 | $158.3M | $932.1M | ||
| Q2 24 | $147.0M | $951.9M |
总资产ARDXRAMP
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $1.3B | ||
| Q3 25 | $486.2M | $1.2B | ||
| Q2 25 | $466.8M | $1.2B | ||
| Q1 25 | $410.2M | $1.3B | ||
| Q4 24 | $435.8M | $1.3B | ||
| Q3 24 | $367.9M | $1.2B | ||
| Q2 24 | $343.5M | $1.2B |
负债/权益比ARDXRAMP
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
RAMP
暂无分部数据
